CompletedNot applicableNCT03510156

Treatment of Disruptive Behaviors in Fragile X Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stanford University
Principal Investigator
Scott S Hall, PhD
Stanford University
Intervention
Behavior analytic treatment(behavioral)
Enrollment
60 enrolled
Eligibility
3-10 years · MALE
Timeline
20162022

Study locations (1)

Collaborators

The John Merck Fund

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03510156 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials